News Mycenax Biotech Inc.

Equities

4726

TW0004726005

End-of-day quote Taipei Exchange Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
43.45 ^TWD	-0.23%		-6.16%	+21.71%

Mar. 14	Mycenax Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 13	Mycenax Biotech Inc. Announces the Appointment of Li-Ju Yeh as Corporate Governance Officer	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Mycenax Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 13	CI
Mycenax Biotech Inc. Announces the Appointment of Li-Ju Yeh as Corporate Governance Officer	Mar. 13	CI
Mycenax Biotech Inc. cancelled the transaction announced on March 13, 2023	Mar. 12	CI
Mycenax Biotech Inc. announced that it expects to receive funding from Center Laboratories, Inc., JCR Pharmaceuticals Co., Ltd., Taiwan BioVenture Company, Jason Technologies Ltd	Mar. 12	CI
Mycenax Biotech Inc. Announces Resignation of Stacy Sun as Corporate Governance Officer, Effective on February 29, 2024	Feb. 27	CI
Mycenax Biotech Inc. Announces Board Changes	Feb. 19	CI
Mycenax Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
Mycenax Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10	CI
Mycenax Biotech Inc. Announces Resignation of Yu-Ching Chang as Financial and Accounting Officer, Effective on August 11, 2023	23-08-02	CI
Mycenax Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
Mycenax Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-13	CI
Mycenax Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-13	CI
Mycenax Biotech Inc. announced a financing transaction	23-03-12	CI
Mycenax Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-11	CI
Mycenax Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-11	CI
Mycenax Biotech Inc. announced that it expects to receive TWD 1.659112761 billion in funding from JCR Pharmaceuticals Co., Ltd., Center Laboratories, Inc.	22-07-26	CI
Mycenax Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-13	CI
Mycenax Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-24	CI
Mycenax Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-11	CI
Mycenax Biotech Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Mycenax Biotech Inc.

Equities

4726

TW0004726005

Summary

Filters